Creatine: The Most-Studied Supplement and What It Actually Does
Decades of trials back creatine for muscle and strength, and newer research is testing brain benefits, but the hype has outrun some of the data.
Aug 19, 2024

Search
41 stories for“clinical trials”
Decades of trials back creatine for muscle and strength, and newer research is testing brain benefits, but the hype has outrun some of the data.
Aug 19, 2024

Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024

A phase 1 trial at the Charite in Berlin used CD19 CAR T cells, a treatment built for blood cancers, on patients who had already failed between five and eight biologic drugs. Disease activity fell in every one of them. Three reached medication free remission.
Aug 30, 2026

Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026

DiRECT reported 46 per cent remission at one year and 36 per cent at two. Among those who lost more than ten kilograms, three quarters were in remission. At five years, the picture is more sobering and more useful.
Aug 12, 2026

Meta-analyses now put exercise's effect on depression in the same range as antidepressant trials, with real implications for regions like the Gulf.
Apr 14, 2026

Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024

Trial data on stopping semaglutide shows most of the lost weight comes back within a year. Here is what the STEP 1 extension found.
May 15, 2024

Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026

A tiny implant paired with camera glasses can return useful central vision to some people with advanced macular degeneration, and Europe has cleared its sale.
Jul 23, 2026

Two individualized antisense treatments reduced the effects of a rare SCN2A disorder. The results are hopeful, but they come from two carefully monitored patients, not a broad trial.
Aug 1, 2026

Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025

Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.
Mar 13, 2024

Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024

TRIUMPH-2 and TRIUMPH-3 read out in July, following TRIUMPH-1 in May. Across the programme the triple agonist has produced weight loss in a range no approved obesity drug has reached, with a filing due in early 2027.
Aug 11, 2026

An engineered gum reduced HPV and nearly eliminated two bacteria linked to head and neck cancer. It is early work, and the delivery method is the genuinely clever part.
Aug 6, 2026

Nausea is the least of it. Here is an honest look at GLP-1 side effects, the thyroid warning, pancreatitis and who is advised to avoid them.
Jul 10, 2024

Lilly does not expect to file for approval until the first quarter of 2027. Search the drug's name today and you can have a vial by the weekend. The gap between those two facts is where the harm happens.
Aug 20, 2026

The only licensed Ebola vaccine was made for Zaire ebolavirus. The outbreak killing people in eastern Congo is Bundibugyo. Vaccination began this week anyway, with 20,000 of the 70,000 doses formally designated as a trial.
Aug 29, 2026

Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026

Estrogen-only therapy was associated with 39 per cent lower odds of dementia, and with fewer amyloid plaques and tau tangles in donated brains. It is observational, and the group that receives it is unusual.
Aug 22, 2026

Over-the-counter glucose monitors reached healthy consumers in 2024, but research suggests their readings may not mean what wearers assume.
Jul 22, 2025

New mortality data pinpoints how much weekly strength training lowers death risk, and shows more is not always better.
Apr 10, 2025

On 23 and 24 July, an FDA advisory committee looked at seven peptides and recommended that pharmacies be allowed to compound several of them. The vote is not binding, and the evidence gap has not moved.
Aug 11, 2026

New body composition data compares lean mass loss on tirzepatide and semaglutide. Here is what is measured, and what remains unclear.
Jun 15, 2026

Doctors and followers spent a year disagreeing about nizam al-tayyibat without ever contradicting each other, because they were not answering the same question.
Jul 24, 2026

One in five people who live through conflict develops a mental health condition. Most of the useful advice is unglamorous: fix sleep, ration news, keep routine, and treat connection as a necessity rather than a nicety.
Aug 13, 2026

VO2 max strongly predicts longevity, but the evidence that slow, low-intensity Zone 2 training is the best way to raise it is weaker than the trend suggests.
Jan 15, 2025
